Viewing Study NCT04558892


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-03-27 @ 8:43 AM
Study NCT ID: NCT04558892
Status: TERMINATED
Last Update Posted: 2023-01-30
First Post: 2020-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.
Sponsor: Military Institute od Medicine National Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nephrotic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nephrotic syndrome View
None Enoxaparin View
None Low molecular weight heparin View
None Anti-Xa activity View
None Antifactor Xa View
None Venous thromboembolism View